Funding for this research was provided by:
National Research and Development Program Hungary (NKFP-1/0003/2005)
Received: 20 July 2017
Accepted: 1 May 2018
First Online: 19 May 2018
Ethics approval and consent to participate
: The study was approved by the ethical committee of the University of Debrecen [Regional and Institutional Ethics Committee, Clinical Centre, University Of Debrecen; number: 2698–2007]. All participants gave written informed consent to participate in the study.
: VP is a full-time employee of GlaxoSmithKline Ltd., which has a financial interest related to the prevention of cervical cancer as the producer of a human papillomavirus vaccine. ZV regularly provided consultancy service for GlaxoSmithKline Hungary Ltd. as the member of its advisory board on vaccination and received funding for other research from the company.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.